LPL Financial LLC Buys New Position in Privia Health Group, Inc. (NASDAQ:PRVA)

LPL Financial LLC purchased a new stake in Privia Health Group, Inc. (NASDAQ:PRVA) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 10,167 shares of the company’s stock, valued at approximately $199,000.

Other institutional investors have also added to or reduced their stakes in the company. Riverbridge Partners LLC raised its position in shares of Privia Health Group by 19.7% in the 4th quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company’s stock valued at $113,868,000 after purchasing an additional 958,418 shares during the last quarter. Franklin Resources Inc. raised its holdings in shares of Privia Health Group by 2.2% in the third quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock worth $23,092,000 after buying an additional 28,480 shares during the last quarter. Charles Schwab Investment Management Inc. raised its holdings in shares of Privia Health Group by 6.5% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,133,873 shares of the company’s stock worth $22,167,000 after buying an additional 69,649 shares during the last quarter. Sei Investments Co. grew its holdings in shares of Privia Health Group by 26.2% during the fourth quarter. Sei Investments Co. now owns 573,635 shares of the company’s stock valued at $11,215,000 after buying an additional 119,052 shares during the last quarter. Finally, Nordea Investment Management AB increased its position in shares of Privia Health Group by 33.1% in the 4th quarter. Nordea Investment Management AB now owns 349,773 shares of the company’s stock valued at $6,953,000 after acquiring an additional 86,910 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

Insider Buying and Selling

In other news, CFO David Mountcastle sold 5,630 shares of the business’s stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total value of $125,999.40. Following the completion of the sale, the chief financial officer now directly owns 179,676 shares in the company, valued at $4,021,148.88. The trade was a 3.04 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 10.70% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of brokerages have commented on PRVA. Canaccord Genuity Group lifted their price target on Privia Health Group from $29.00 to $30.00 and gave the stock a “buy” rating in a research report on Friday, February 28th. Stephens reaffirmed an “overweight” rating and set a $26.00 target price on shares of Privia Health Group in a report on Thursday, January 2nd. JMP Securities reiterated a “market outperform” rating and issued a $29.00 price target on shares of Privia Health Group in a report on Monday. Robert W. Baird lifted their price objective on shares of Privia Health Group from $24.00 to $26.00 and gave the company an “outperform” rating in a research note on Tuesday, April 15th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $30.00 price objective on shares of Privia Health Group in a report on Thursday, April 10th. One analyst has rated the stock with a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $27.14.

Privia Health Group Stock Up 0.9 %

PRVA stock opened at $23.41 on Wednesday. Privia Health Group, Inc. has a 52-week low of $15.92 and a 52-week high of $26.04. The firm has a market cap of $2.84 billion, a P/E ratio of 234.12, a PEG ratio of 3.47 and a beta of 0.88. The company’s 50-day simple moving average is $23.57 and its 200-day simple moving average is $21.98.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.